CBT Stock Recent News

Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth.

Cabot (CBT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BOSTON--(BUSINESS WIRE)--On Friday, January 10, 2025, the Board of Directors of Cabot Corporation (NYSE: CBT) declared a quarterly dividend of $0.43 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on March 14, 2025, to stockholders of record at the close of business on February 28, 2025. About Cabot Corporation Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The.

BOSTON--(BUSINESS WIRE)--Cabot Corporation to Announce First Quarter 2025 Operating Results.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Cabot (CBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

DuPont de Nemours, FMC and Cabot have been highlighted in this Industry Outlook article.

Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, FMC and CBT are poised to navigate the industry challenges.

CBT benefits from robust demand across the automotive, infrastructure and semiconductor markets and improved product mix.

BOSTON--(BUSINESS WIRE)--Cabot Corporation to Host 2024 Investor Day.